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Abstract 
Objective: This study describes the occurrence of a silent mutation in the RNA binding domain of nucleocapsid 
phosphoprotein (N protein) coding gene from SARS-CoV-2 that may consequence to a missense mutation by onset 
of another single nucleotide mutation.
Results: In the DNA sequence isolated from severe acute respiratory syndrome (SARS-CoV-2) in Iran, a coding 
sequence for the RNA binding domain of N protein was detected. The comparison of Chinese and Iranian DNA 
sequences displayed that a thymine (T) was mutated to cytosine (C), so “TTG” from China was changed to “CTG” in 
Iran. Both DNA sequences from Iran and China have been encoded for leucine. In addition, the second T in “CTG” in 
the DNA or uracil (U) in “CUG” in the RNA sequences from Iran can be mutated to another C by a missense muta-
tion resulting from thymine DNA glycosylase (TDG) of human and base excision repair mechanism to produce “CCG” 
encoding for proline, which consequently may increase the affinity of the RNA binding domain of N protein to viral 
RNA and improve the transcription rate, pathogenicity, evasion from human immunity system, spreading in the 
human body, and risk of human-to-human transmission rate of SARS-CoV-2.
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Introduction
Coronaviruses (CoVs) are the causative agent of diversity 
of infections in birds and mammals such as upper res-
piratory infection of chickens and enteritis in pigs and 
cows [1]. In addition to animals, human can be infected 
with different isolates of CoVs such as severe acute res-
piratory syndrome coronavirus (SARS-CoV) and Mid-
dle East respiratory syndrome coronavirus (MERS-CoV) 
with common cold, bronchitis, and pneumonia symp-
toms [2]. CoVs contain a positive-sense RNA strand with 
the genome size between 26.2 and 31.7 kb. The genomes 
of CoVs contain 3′ poly (A) and 5′ cap structures play as 
a mRNA in the translation activity of replicase enzyme 
[3]. It is specified that about 70% of the total size of the 
genome is occupied by replicase gene (20  kb) encoding 
for nonstructural proteins (nsp), while about 10  kb of 
the genome encodes for structural and accessory pro-
teins. The studies have shown that the accessory pro-
teins are not necessary for the viral replication, while 
are required in the CoVs pathogenesis and morphogen-
esis [4]. The CoVs contain four main structural proteins 
including spike (S), membrane (M), nucleocapsid (N), 
and envelope (E), which are expressed by the 3′ end of 
RNA genome [5]. S protein (150  kDa) contains a sig-
nal peptide sequence at the N-terminal with the abil-
ity to lead the S proteins to endoplasmic reticulum (ER) 
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abundant structural protein containing three transmem-
brane domains, which play a role in the virion formation. 
M proteins contain a small glycosylated N-terminal with 
the capability to bind to nucleocapsid so the M–N pro-
teins binding may stabilize the complexes in the assembly 
of CoVs [7]. N protein (50–60 kDa) has the RNA binding 
capability by both N-terminal domain (NTD) and C-ter-
minal domain (CTD) with two different mechanisms [8]. 
Three main factors have the crucial roles in the binding 
of N protein to RNA including phosphorylation of N pro-
tein, transcription regulatory signal (TRS), and genomic 
packaging signal (GPS). N protein binds to RNA, M pro-
tein, nsp3, replicase-transcriptase complex (RTC), which 
finally packages the RNA genome into CoVs. E protein 
(8–12  kDa) is a transmembrane protein with ion chan-
nel activity so that the lipid membrane charges affect 
the cation preference of these ion channels [9]. E protein 
facilitates the assemblage and release of virions from the 
infected cells. E protein is not necessary for CoV replica-
tion, while it is required for the CoV pathogenesis [10]. 
The studies revealed that SARS-CoV enters to the host 
cell using angiotensin converting enzyme 2 (ACE2) as the 
host receptor, while the host cell receptor for MERS-CoV 
is Dipeptidyl peptidase 4 (DPP4) [11].
Since December 2019, a novel member of CoVs have 
emerged from an outbreak in Wuhan, China, later on 
the causative agent was nominated as SARS-CoV-2 and 
the infection was nominated as coronavirus disease 2019 
(COVID-19) [12]. Thereupon, the World Health Organi-
zation declared COVID-19 as a pandemic infection in 
March 2020 [13–15].
In this study and through a biodata mining approach, 
we evaluated a partial RNA binding domain of nucle-
ocapsid protein (N protein) coding gene of SARS-CoV-2 
isolated in Iran. In this coding gene, we found a silent 
thymine (T) to cytosine (C) mutation expressing leucine, 
which the encoded amino acid was similar to the query 
DNA sequence from Wuhan, China. This study alerts 
the incidence of second single nucleotide mutation in 
the subject coding sequence in Iran with the equal prob-
ability happened in the first T and changing middle T 
in DNA or U in RNA to C to form “CCG”. The encoded 
leucine will be changed to proline, which can influence 
the RNA binding activity of N protein and pathogenicity 
of SARS-CoV and induction of human immune system 




The coding gene for RNA binding domain of N protein 
of SARS-CoV-2 isolated in Iran was extracted from NCBI 
Virus database (https ://www.ncbi.nlm.nih.gov/labs/virus 
/vssi/#/) [16]. The accession number of MT186676 was 
identified, which was related to a DNA sequence with 
363 b in length, isolated in Iran, and annotated in the 
NCBI Virus database on 2020-03-13. The details of this 
annotated DNA sequence has been described as “Severe 
acute respiratory syndrome coronavirus 2 isolate SARS-
CoV-2/1337/human/2020/IRN nucleocapsid phospho-
protein (N) gene, partial cds (Mokhtari Azad et  al.)”. 
The accession number of encoded protein is QIK02784, 
which was nominated as partial nucleocapsid phospho-
protein with 122 amino acids in length.
The Iranian CDS sequence (MT186676) and the query 
CDS sequence from Wuhan, China (NC_045512.2) were 
aligned using Clustal Omega algorithm (https ://www.
ebi.ac.uk/Tools /msa/clust alo/) [17] of multiple sequence 
alignment (MSA). Then, the partial nucleocapsid phos-
phoprotein (QIK02784) from Iran and the query protein 
sequence from Wuhan, China (QIE07458) were aligned 
using Clustal Omega algorithm of MSA.
Structural analysis
MT186676 related to the partial nucleocapsid phos-
phoprotein from Iran was analyzed in the RCSB Protein 
Data Bank (PDB) (https ://www.rcsb.org/) [18]. In this 
data bank, a basic local alignment search tool (BLAST) 
was used to detect the most identical PDB identification 
number related to a crystalized protein to the Iranian 
protein sequence. In the next step, the NGL (WebGL) 
viewer [19] was employed to visualize NMR structure of 
the most identical protein structure to the partial nucle-
ocapsid phosphoprotein from Iran.
Results
Sequence analysis
The MSA analysis of the CDS sequence coding for the 
partial RNA binding domain of N protein of SARS-
CoV-2 isolated in Iran (MT186676) and the query CDS 
sequence from Wuhan, China (NC_045512.2) showed 
high similarity in both CDS sequences. A nucleotide 
mismatch was identified at nucleotide No. 312 that 
mutates T to C. The analysis revealed that both coding 
nucleotide sequences including “TTG” in the query CDS 
sequence from Wuhan, China and “CTG” in the subject 
CDS sequence from Iran encode for leucine (Fig. 1a). In 
addition, the MSA analysis of the query protein sequence 
from Wuhan, China (QIE07458) and the partial RNA 
binding domain of N protein from Iran (QIK02784) 
showed 100% similarity in both protein sequences 
(Fig. 1b and c) (Additional file 1: Fig. S1).
Structural analysis
The structural analysis of the partial RNA binding 
domain of N protein from Iran (QIK02784) in the RCSB 
Page 3 of 6Zolfaghari Emameh et al. BMC Res Notes           (2021) 14:10  
PDB Protein Data Bank defined that the NMR entry ID: 
6VYO belongs to the crystal structure of RNA binding 
domain of N protein from SARS-CoV-2 with E-value: 
6.19076E−76, which in comparison to each other 
sequences showed 100% identity. This tetrameric pro-
tein structure contains four Glu62 and Glu136 with the 
highest exposure rate at the surface of the protein, while 
Leu139 encoded by the silent mutation (CTG) showed 
Fig. 1 MSA analysis of RNA binding domain of N protein sequence. a MSA analysis of the CDS subject from Iran with the CDS query from Wuhan, 
China (yellow highlight); b MSA analysis of the partial RNA binding domain of N protein sequence from Iran with the query protein sequence from 
Wuhan, China (cyan highlight). Although both analyses show high similarity, a mismatch nucleotide is shown by the red circles in part A and B; and 
(c) The coding sequences of “TTG” in the CDS query sequence from Wuhan, China and “CTG” in the CDS subject sequence from Iran, which both 
encode for leucine
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less exposure rate (Fig.  2). The analysis of the crys-
tal structure of 6VYO revealed that the RNA binding 
domain of N protein from SARS-CoV-2 is a tetrameric 
structure, which each monomer contains three binding 
sites to unique ligands including zinc ion  (Zn2+), glyc-
erol (GOL), and 2-(N-morpholino)-ethanesulfonic acid 
(MES) (Fig. 3).
Discussion
The comparison of both CDS and protein sequences 
for subject from Iran and query from Wuhan, China by 
the MSA method revealed that the subject sequence 
from Iran is the partial RNA binding domain of N pro-
tein from SARS-CoV-2. The studies revealed that N 
protein is phosphorylated, which triggers the binding 
affinity of N protein to the RNA genome of SARS-CoV-2 
[5, 20]. In addition, both TRS and GPS are considered 
as the main factors of binding of N protein to the viral 
RNA. The further analysis revealed that the CDS subject 
sequence from Iran contains a silent mutation, which 
changed “TTG” in the CDS query sequence to “CTG”. 
Although both “TTG” and “CTG” encode for leucine, the 
occurrence of mutation in the middle T in “CTG” with 
the equal probability will change the encoded leucine 
(Leu139) to proline (Pro139).
In SARS-CoV-2, the mutations can occur under the 
pressure of the human immune system, which can be 
associated with increasing the transmission rate and 
Fig. 2 Protein structure of the RNA binding domain of N protein. The 
NMR structure entry ID: 6VYO was visualized by the NGL (WebGL) 
viewer. The exposure rate of eight glutamines including four Glu62 
and four Glu136 in the tetrameric protein structure is higher than 
Leu139 encoded by the silent mutated sequence
Fig. 3 Tetrameric structure of the RNA binding domain of N protein from SARS-CoV-2. Each monomer contain one binding site for unique ligands 
including zinc ion  (Zn2+), glycerol (GOL), and 2-(N-morpholino)-ethanesulfonic acid (MES)
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pathogenicity of the virus. It is speculated that single 
mutation of first T in “TTG” to C to form “CTG” can 
be one of the changes occurred under the pressure of 
immune system. Changing the middle T to C to form 
“CCG” for encoding proline instead of leucine can be 
one of the evolutionary strategies of SARS-CoV-2. It is 
speculated that the middle T in “CTG” or middle U in 
“CUG” have undergo a G:T (in DNA) or G:U (in RNA) 
mismatch, which was repaired by employing thymine 
DNA glycosylase (TDG) of human and base exci-
sion repair system with replacing the middle T to C. 
Although TDG is a crucial enzyme in the human DNA 
repair system, it seems that TDG can be employed 
within the SARS-CoV-2 genome organization during 
the COVID-19 infection in human as well. Further 
biochemical analysis of constituent amino acids of the 
RNA binding domain of N protein from SARS-CoV-2 
defined that not only the exposure rate of the RNA 
binding domain of N protein is increased with replace-
ment of leucine with proline, but also increase the 
chance of immune evasion of this protein [21]. There-
fore, this missense mutation may increase the bind-
ing rate of N protein to the viral RNA; improving the 
transcription rate of the viral RNA, escaping from the 
human immune system, and consequently raise inci-
dence of COVID-19 cases with higher pathogenicity 
rate in Iran.
The probability of emerge of next generation of 
SARS-CoV-2 in Iran through this missense muta-
tion has the potential to be transmitted worldwide 
by human-to-human contacts as well. This happen-
ing may prepare more human-to-human transmission 
cases, which consequently rise the risk of evolution of 
SARS-CoV-2 by accumulation of silent mutations lead-
ing to a missense mutation [22]. The study of bind-
ing sites of unique ligands including  Zn2+, GOL, and 
MES to the RNA binding domain of N protein dem-
onstrated  Zn2+ coordination has a major role in the 
geometry of tetrahedral structure of protein; GOL 
plays the role in the stability of protein, and MES is 
associated with the preparation of buffering condi-
tion for the protein [23]. Therefore, the ligand binding 
information can provide the invaluable opportunities 
to chelate  Zn2+ by appropriate inhibitors as an antivi-
ral therapy. The chelation of  Zn2+ and the early stage 
inhibition of replication had been studied in dengue 
virus [24]. On the other hand, another study showed 
that RNA-dependent RNA polymerase (RdRp) of 
nidovirus, a CoV member, is inhibited by  Zn2+ [25]. 
Hence, focusing on  Zn2+,  Zn2+ chelating agents, and 
inhibition of  Zn2+-associated enzymes and proteins 
[24–26] potentially may be a pharmaceutical measure 
to treat COVID-19.
Conclusion
In conclusion, the more opportunities for human-to-
human transmission,the more occurrence of missense 
mutation risk, improving the replication and transcrip-
tion rates, and raising the virulence and pathogenicity 
of SARS-CoV-2. In addition,  Zn2+ and  Zn2+ inhibition 
studies have the potentials to become a medication 
compound and strategy against COVID-19. Moreo-
ver, our results revealed that TDG of human can be 
employed by SARS-CoV-2 during the genome organi-
zation and repairing leading to emerge of another 
mutated SARS-CoV-2 strain, which this mechanism 
has not reported yet by molecular virology studies of 
SARS-CoV-2 and needs to be examined by further 
experimental studies in the future.
Limitations
This study was performed based on the bioinformatics 
and computational analyses. In addition, further muta-
tions may be occurred in the genome of SARS-CoV-2 
to increase the transcription rate of viral RNA, patho-
genicity of virus, evasion from the human immune sys-
tem, spreading in the human body, binding of virus to 
cell receptors, and human-to-human transmission rate.
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